Abstract 1706: A non-canonical MiT/TFE-dependent NRF2 program is a druggable vulnerability in multiple cancer types

MLA

Xinbo Luo, et al. “Abstract 1706: A Non-Canonical MiT/TFE-Dependent NRF2 Program Is a Druggable Vulnerability in Multiple Cancer Types.” Cancer Research, vol. 83, Apr. 2023, p. 1706. EBSCOhost, https://doi.org/10.1158/1538-7445.am2023-1706.

APA

Xinbo Luo, Bart Lutterbach, Priya Pancholi, Yeon Sook Choi, Xiao Liu, Phillip Munson, Saqib Faisal, David A. Whipple, Robert A. Smith, Warren S. Weiner, David K. Johnson, Myriam Boukhali, Nicole S. Persky, Matthew G. Rees, Shunsuke Kitajima, David Barbie, Anuradha Roy, Michael Baltezor, Lian Rajewski, … Rizwan Haq. (2023). Abstract 1706: A non-canonical MiT/TFE-dependent NRF2 program is a druggable vulnerability in multiple cancer types. Cancer Research, 83, 1706. https://doi.org/10.1158/1538-7445.am2023-1706

Chicago

Xinbo Luo, Bart Lutterbach, Priya Pancholi, Yeon Sook Choi, Xiao Liu, Phillip Munson, Saqib Faisal, et al. 2023. “Abstract 1706: A Non-Canonical MiT/TFE-Dependent NRF2 Program Is a Druggable Vulnerability in Multiple Cancer Types.” Cancer Research 83 (April): 1706. doi:10.1158/1538-7445.am2023-1706.